(Q43598189)
Statements
1 reference
A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression (English)
1 reference
Brendon Binneman
1 reference
Douglas Feltner
1 reference
Sheela Kolluri
1 reference
Yuanjun Shi
1 reference
Ruolun Qiu
1 reference
Thomas Stiger
1 reference
15 April 2008
1 reference
1 reference
Identifiers
1 reference